Hongxia Dong
发表
CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation.
Chenggang Zhang,
Weiguang Li,
Changhui Ge,
2016,
Annals of translational medicine.
Z. Qiu,
Xiaobo Peng,
Hongxia Dong,
2013,
International journal of dermatology.